Ultima Genomics
Ultima Genomics is a US-based genomics technology company that develops ultra-high-throughput, low-cost DNA sequencing platforms (the UG 100/UG200 series). Its novel sequencing architecture enables population-scale genomics to advance biological research and improve human health.
Analytics date: 28.10.2026
Basic information
Head office
4209 Technology Drive, Fremont, CA 94538, United StatesHead officeGeography of business
United States of America- Netherlands
- Germany
Geography of businessDate of the last round
Last round 06/2022Date of the last roundTotal funds raised
$613.8M+Total funds raisedPrice per share
$20.00Price per sharePrice per share. Based on the latest known transaction. It is not an offer or investment recommendation.
Analytics date: 28.10.2026
IPO Forecast
No IPO plans announced. No filing, banker, exchange or timeline reported.
Request price information
Competitor Analysis
Comparison with other companies in the industry.
| Name | Valuation |
| Private companies | |
Isomorphic Labs | 00 |
Colossal Biosciences | 00 |
Varda Space Industries | 000 |
Mammoth Biosciences | 00000 |
NaturalCycles | 0000 |
| Traded companies | |
Recursion Pharmaceuticals | 000 |
Schrödinger | 0000 |
Relay Therapeutics | 000 |
Scribe Therapeutics | 00000 |
Metagenomi Therapeutics | 0000 |